Physician profile
Robert Sickler
NPI 1952338279
$4,912.92
in general payments reported to CMS, 2019-2025
24 companies · $268 in 2025
The $268 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,510 · 2020: $441 · 2021: $547 · 2022: $406 · 2023: $449 · 2024: $293 · 2025: $268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,009.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,008.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertiflex, INC. | $2,071.19 | 2019 | |
| Nevro Corp. | $685.62 | 2019-2024 | Senza |
| Collegium Pharmaceutical, INC. | $423.34 | 2019-2025 | Belbuca |
| Medtronic, INC. | $253.95 | 2021-2023 | Intellis Adaptivestim, Percept PC Brainsense |
| Boston Scientific Corporation | $251.43 | 2021-2025 | Intracept |
| Abbott Laboratories | $229.98 | 2019-2021 | |
| Globus Medical, INC. | $186.96 | 2025 | Senza |
| Scilex Pharmaceuticals INC. | $122.63 | 2019-2024 | |
| Horizon Therapeutics Plc | $92.46 | 2019-2022 | |
| Painteq LLC | $77.24 | 2024 | Painteq |
| Electronic Waveform Lab, INC. | $69.91 | 2022 | |
| Almatica Pharma LLC | $65.99 | 2021-2023 | Gralise |
| Assertio Therapeutics, INC. | $61.21 | 2019 | |
| Relievant Medsystems, INC. | $58.37 | 2021 | |
| Saluda Medical Americas, INC. | $52.28 | 2024 | Evoke |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $47.56 | 2023 | Relistor |
| Vertos Medical, INC. | $35.45 | 2022 | |
| Merck Sharp & Dohme LLC | $25.37 | 2024 | Bridion |
| Biotissue Holdings INC. | $24.20 | 2021 | |
| Averitas Pharma INC. | $22.59 | 2025 | Qutenza |
| Stimwave Technologies Incorporated | $17.20 | 2020 | |
| Nalu Medical, INC. | $14.50 | 2023 | Nalu Neurostimulation System |
| Emergent Biosolutions INC. | $12.55 | 2019 | |
| Si-Bone, INC. | $10.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Sickler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.